StockWatch
·
 Medicinal Chemicals and Botanical Products
RegulatoryJun 26, 2026, 04:44 PM

Upexi receives Nasdaq non-compliance notice; added to Russell Microcap

AI Summary

Upexi, Inc. received a Nasdaq non-compliance notice on June 24, 2026, for failing to obtain shareholder approval for two convertible note issuances totaling approximately $187 million, violating Nasdaq Listing Rule 5635(a). The company has 45 days to submit a plan to regain compliance. Separately, Upexi announced its inclusion in the Russell Microcap® Index, effective June 29, 2026, aiming to boost institutional investor visibility.

Key Highlights

  • Nasdaq non-compliance notice received June 24, 2026, for Rule 5635(a) violation.
  • Failed to obtain shareholder approval for two convertible note issuances.
  • First issuance: $151.17 million secured convertible notes on July 9, 2025.
  • Second issuance: $36 million secured convertible note on January 9, 2026.
  • Notes convertible into 20% or more of pre-transaction shares and voting power.
  • Company has 45 days (until August 10, 2026) to submit a compliance plan.
  • Added to Russell Microcap® Index, effective June 29, 2026.